Search results
Results From The WOW.Com Content Network
Public Bank Berhad: Banking 5,578 1,459 19,827 Kuala Lumpur 10 Batu Kawan Berhad: Chemicals 5,449 109 42,559 Ipoh: 11 Kuala Lumpur Kepong Berhad: Agribusiness 5,226 184 48,487 Kuala Lumpur 12 YTL Power: Utilities 4,877 452 4,800 Kuala Lumpur 13 Axiata: Telecommunications 4,829 -438 10,800 Kuala Lumpur 14 IHH Healthcare: Healthcare 4,595 648 ...
Adventa Berhad (MYX: 7191) is a Malaysian holding company. It is headquartered in Petaling Jaya, Selangor, and is part of the Management of Companies and Enterprises Industry. [1] It was founded in 2004. Adventa initially invested in the glove-making business. In 2012, the group divested the glove business to Aspion.
The economy of Malaysia (GDP PPP) in 2014 was $746.821 billion, the third largest in ASEAN behind Indonesia and Thailand and the 28th largest in the world. [6] [needs update] For further information on the types of business entities in this country and their abbreviations, see "Business entities in Malaysia".
Parkway Pantai, Ltd. is a medical company based in Singapore and is Southeast Asia's largest private healthcare provider, and one of the largest in Asia.It is a wholly owned subsidiary of Kuala Lumpur-based IHH Healthcare, whose largest shareholder is Malaysian state investment agency Khazanah Nasional. [1]
IOI develops real estate and makes property investments in commercial, hospitality and leisure, launching its maiden 930-acre Bandar Puchong Jaya township in 1990. [3] IOI announced a demerger of its property business in 2013, [11] and relisted it as IOI Properties Group Berhad on the Main Market of Bursa Malaysia on 15 January 2014.
Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology, molecular pathology, and Immunohaematology.
With five manufacturing plants, including Indonesia plant, Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables. Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, diabetes, anti-infectives, pain management, and respiratory ...
In 2014, Dr Lal PathLabs acquired the APL Clinical Institute of Clinical Laboratory & Research Private Limited. [6] Dr Lal PathLabs launched its IPO in 2015. [7] The company got listed on BSE and NSE on 23 December 2015. [8] In 2021, Dr Lal PathLabs acquired Suburban Diagnostics for an enterprise value of ₹ 925 crore in an all-cash deal. [9]